Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis

Abstract Background Acute myeloid leukemia (AML) is characterized by the abnormal proliferation of myeloid precursor cells and presents significant challenges in treatment due to its heterogeneity. Recently, the NLRP3 inflammasome has emerged as a potential contributor to AML pathogenesis, although...

Full description

Bibliographic Details
Published in:Cell Communication and Signaling
Main Authors: Michela Luciano, Helene Sieberer, Peter W. Krenn, Hieu-Hoa Dang, Julia Vetter, Theresa Neuper, Diana Amend, Constantin Blöchl, Christian X. Weichenberger, Anna Eglseer, Michael S. Unger, Ancuela Andosch, Philip Steiner, Daniel Neureiter, Renate Bauer, Laura Hummer, Suzana Tesanovic, Stephanie Binder, Dominik P. Elmer, Helen Strandt, Susanne Schaller, Dirk Strunk, Lisa Pleyer, Richard Greil, Stephan Winkler, Tanja N. Hartmann, Dirk Schmidt-Arras, Christian G. Huber, Fritz Aberger, Jutta Horejs-Hoeck
Format: Article
Language:English
Published: BMC 2024-09-01
Subjects:
Acute myeloid leukemia
Apoptosis
eIF2α, NLRP3
PERK
Online Access:https://doi.org/10.1186/s12964-024-01777-6

Similar Items

Similar Items